ARDX
Ardelyx, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.78
+1.89%Leverage
- Debt / equity
- 1.72x
- Net debt / equity
- 1.07x
- Debt / assets
- 0.44x
- Debt / EBITDA
- -10.77x
- Net debt / EBITDA
- -6.69x
Liquidity & coverage
- Current ratio
- 3.34x
- Quick ratio
- 3.15x
- Cash ratio
- 2.13x
- Interest coverage
- -1.29x
- EBITDA / interest
- -0.87x
- Working capital
- $309.7M
Cash & dividend
- FCF / debt
- -0.07x
- Cash flow / debt
- -0.07x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026